Skip to main content
Elsevier

Journals in Microbiology and virology

Elsevier's Microbiology & Virology collection provides comprehensive coverage of viruses and microorganisms, addressing their impact on human, animal, and plant health. It includes topics such as prevention, treatment, and research of viral diseases like coronaviruses, flaviviruses, and viral hemorrhagic fevers. The collection delves into fields like Bacteriology, Mycology, and Microbial genetics, focusing on their roles in environmental, agricultural, and health-related contexts. This resource serves as a vital tool for scientists, facilitating the study of viruses and microorganisms and enabling the development of effective strategies for infectious disease prevention, diagnosis, and control.

  • Physiological and Molecular Plant Pathology

    • ISSN: 0885-5765
    Physiological and Molecular Plant Pathology provides an international forum for original research papers, short communications and reviews on all aspects of molecular biology, biochemistry, physiology, histology and cytology, genetics and evolution of plant-microbe interactions.Papers on all kinds of infective pathogens, including viruses, viroids, prokaryotes, fungi, and nematodes, as well as mutualistic organisms such as Rhizobium, mycorrhizal fungi and other beneficial microbes which are effective in plant protection against diseases, are acceptable as long as they have a bearing on the interaction between pathogen and plant.This journal publishes studies that apply artificial intelligence (AI), internet of things (IoT), and machine learning (ML) for improvement of knowledge on host-pathogen interactions, disease detection and control strategies, physiological and molecular mechanisms related to infection processes of pathogens and plant defense, supported by validation via in vitro and in vivo biological assays.Research Areas Include:• Recognition in plant immunity• Cell biology of plant-microbe interactions• Plant molecular defense responses, including transcriptome, proteome, miRNA profiling, metabolome• Mechanisms of specific resistance, induced resistance and non-host -resistance• Plant hormones and regulators in plant-microbe interactions• Molecular biology of phytoalexins and other secondary metabolites of the host and their roles in resistance• Pathogen effectors involved in pathogenicity and interaction with the host• Pathogen infection mechanisms and host defense suppression• Novel approaches for disease detection and control or management strategies• Induction of plant immunity and biotechnology of resistance• Pathogen molecular diagnostic.
    Subscriptions

  • Trends in Parasitology

    • ISSN: 1471-4922
    Since its launch as Parasitology Today back in 1985, Trends in Parasitology has become a highly regarded review journal of international importance, reflecting the global significance of medical and veterinary parasites. The journal aims to provide a point of access for communication among researchers in all disciplines of parasitology, covering endoparasites and ectoparasites, as well as their transmission vectors and susceptible hosts.Each monthly issue of TrePar offers authoritative, cutting edge and yet accessible review balanced and comprehensive overview and opinion personal and novel perspective articles. In addition, we publish a variety of short articles that are designed to inform and provoke thoughts in a lively and widely-accessible manner, including science & society discussion of interface between parasitology and the general public, spotlight highlights of recently published research articles, forum single-point hypotheses, parasite/vector of the month modular display of the featured species, letter responses to recent articles in TrePar and trendstalk interviews. Please note that we only publish literature reviews based on published data. Systematic reviews, meta-analysis and unpublished primary research are out of our scope.Articles for TrePar are peer-reviewed and generally commissioned by the editor. However, proposals are encouraged.
    Subscriptions

  • Antiviral Research

    • ISSN: 0166-3542
    Antiviral Research aims to publish manuscripts in the field of prevention and treatment of viral diseases in humans and vertebrate animals, and encourages authors to the submit manuscripts describing the activity of well-defined chemical compounds for the treatment of viral diseases. The journal is an Official Publication of the International Society for Antiviral Research. The types of papers published in Antiviral Research includes original research reports, short communications, commentaries and invited review* articles on the control of viral infections in humans. The journal’s scope encompasses:antivira... drugs, antibodies and host-response modifiers, including their synthesis, in vitro and in vivo testing and mechanisms of action.identificatio... and validation of new drug targets;laboratory animal models of viral diseases for antiviral efficacy testing;evolution of drug-resistant viruses and the development of effective counter measures;pathogenesi... of viral diseases and mechanisms of viral evasion of host immune responses;assessment... of drug safety;new or improved vaccines against viral infections of humans; the prevention and treatment of viral diseases of vertebrate animals, and reports of the testing of veterinary vaccines in the target animal species. All papers must include a sufficiently detailed description of methods to permit other investigators to replicate the experiments. Authors reporting the antiviral effect of a novel small-molecule drug must reveal its chemical structure. Claims of in vitro or in vivo efficacy of a drug or vaccine must be supported by appropriate statistical analysis that must be clearly described in the manuscript.Antiviral Research journal does not publish reports on viral diseases of plants or of insects, crustaceans or other invertebrates. Studies of viral diseases of livestock and companion animals must be clearly related to the development of realistic therapies. Papers on veterinary vaccines should report findings in the target animal species.We discourage the submission of manuscripts reporting the antiviral activity of unpurified natural products, or of partially purified substances of natural origin for which a mechanism of action has not been determined. Manuscripts claiming an antiviral effect of homeopathic products or other highly diluted preparations, or which fail to clearly identify the biological ingredient or molecule responsible for the antiviral activity of an experimental therapy, will not be considered for publication. Articles describing antiseptics with broad-spectrum antimicrobial activity will not be accepted. We discourage the submission of in silico docking studies or other computer-based predictions of antiviral activity that are not supported by data from biological assays. Citations of reports that have not undergone peer review must include the note "[not peer-reviewed]."ISAR members Authors who are ISAR members are encouraged to contact ISAR after their paper has been accepted for publication in order to benefit from their published work being highlighted in ISAR postings on their social media platforms (further details on this will be given in the AVR acceptance letter). *Antiviral Research journal has started a new initiative to publish at least two thematic special issues per year, containing invited reviews in addition to the ad hoc invitations to experts in the areas within the scope of the journal.
    Subscriptions

  • Virology

    • ISSN: 0042-6822
    An Affiliated Journal of the World Society for Virology Launched in 1955, Virology is a broad and inclusive journal that welcomes submissions on all aspects of virology including plant, animal, microbial and human viruses. The journal publishes basic research as well as pre-clinical and clinical studies of vaccines, anti-viral drugs and their development, anti-viral therapies, and computational studies of virus infections. Any submission that is of broad interest to the community of virologists/vaccinol... and reporting scientifically accurate and valuable research will be considered for publication, including negative findings and multidisciplinary work. Virology is open to reviews, research manuscripts, short communication, registered reports as well as follow-up manuscripts.For more information on article types, please visit our guide for authors: https://www.elsevier... Virology offers guaranteed peer review of Follow-Up as well as Research Articles, provided the Corresponding Author is the same and the new manuscript is submitted within 24 months of the previous paper getting accepted.
    Subscriptions

  • Immunology Letters

    • ISSN: 0165-2478
    Published by Elsevier as the official journal of the European Federation of Immunological Societies (EFIS), a member of the International Union of Immunological SocietiesImmunology Letters provides a vehicle for the speedy publication of experimental papers, (mini)Reviews and Letters to the Editor addressing all aspects of molecular, cellular, and clinical immunology. As the official journal of the European Federation of Immunological Societies (EFIS), Immunology Letters supports international consortia of experts. The journal welcomes collaborative contributions dedicated to the state-of-the-art of immunology topics, as well as commentaries on those topics.Preference is given to papers of immediate importance to other investigators. Therefore, the essential criteria for publication are clarity, experimental soundness and novelty. Results contradictory to current accepted thinking or ideas divergent from actual dogmas are considered for publication provided they are based on solid experimental findings. Scientific correspondence to the Editor-in-Chief related to the published papers may also be accepted provided they are short and scientifically relevant to the papers mentioned, in order to provide a continuing forum for discussion.
    Subscriptions

  • Nanomedicine: Nanotechnology, Biology and Medicine

    • ISSN: 1549-9634
    Nanomedicine: Nanotechnology, Biology and Medicine (NBM) is an international, peer-reviewed journal presenting novel, significant, and interdisciplinary theoretical and experimental results related to nanoscience and nanotechnology in the life and health sciences. Content includes basic, translational, and clinical research addressing diagnosis, treatment, monitoring, prediction, and prevention of diseases.Nanomedicin... Nanotechnology, Biology, and Medicine aims to promote the interdisciplinary field of nanomedicine.The journal publishes topics including:artificial cellsregenerative medicinegene therapyinfectious diseasenanotechnolog... celltissue engineeringSub-categ... include synthesis, bioavailability, and biodistribution of nanomedicines; delivery, pharmacodynamics, and pharmacokinetics of nanomedicines; imaging; diagnostics; improved therapeutics; innovative biomaterials; interactions of nanomaterials with cells, tissues, and living organisms; public health; toxicology; theranostics; point of care monitoring; nutrition; nanomedical devices; prosthetics; biomimetics; and bioinformatics.
    Subscriptions

  • The Lancet Infectious Diseases

    • ISSN: 1473-3099
    The Lancet Infectious Diseases is an authoritative forum for key opinion leaders across medicine, government, and health systems to influence clinical practice, explore global policy, and inform constructive, positive change worldwide.As the global leader in clinical infectious diseases, The Lancet Infectious Diseases delivers essential original research, expert review, candid commentary, and breaking news to provide context and perspective on today's most important medical advances across the broad spectrum of clinical infectious diseases.
    Subscriptions

  • Cancer Genetics

    • ISSN: 2210-7762
    The aim of Cancer Genetics is to publish high quality scientific papers on the cellular, genetic and molecular aspects of cancer, including cancer predisposition and clinical diagnostic applications. Specific areas of interest include descriptions of new chromosomal, molecular or epigenetic alterations in benign and malignant diseases; novel laboratory approaches for identification and characterization of chromosomal rearrangements or genomic alterations in cancer cells; correlation of genetic changes with pathology and clinical presentation; and the molecular genetics of cancer predisposition. To reach a basic science and clinical multidisciplinary audience, we welcome original full-length articles, reviews, meeting summaries, brief reports, and letters to the editor.Cancer Genetics is proud to be affiliated with the Cancer Genomics Consortium.
    Subscriptions

Related subjects